Noncholesterol sterols in bile and stones of patients with cholesterol and pigment stones

T E Miettinen, Y A Kesaniemi, H Gylling, H Jarvinen, E Silvennoinen, T A Miettinen – 1 February 1996 – Human bile and cholesterol gallstones contain sterols including methylated (lanosterol and other dimethyl and monomethyl sterols), and demethylated cholesterol precursor sterols (Δ 8‐lathosterol, lathosterol, and desmosterol), plant sterols (campesterol and sitosterol), and cholestanol.

Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible

K Ogasawara, J Uchino, Y Une, Y Fujioka – 1 February 1996 – Portal vein embolization has been used recently to decrease the amount of the liver to be resected and to enhance the function of the remaining hypertrophied lobes. We have observed a strong contact destructivity of absolute ethanol and used it for portal vein embolization. The present study was performed to produce hepatic hypertrophy and to show histopathologic changes that follow ethanol embolization of rat liver.

Cytokine‐induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cells

E Mawet, Y Shiratori, Y Hikiba, H Takada, H Yoshida, K Okano, Y Komatsu, M Matsumura, Y Niwa, M Omata – 1 February 1996 – To clarify the role of intercellular communication in the liver during accumulation of neutrophils, the release of cytokine‐induced neutrophil chemoattractant (CINC) (interleukin‐8 [IL‐8] related protein in rodents) by hepatocytes was investigated in the presence of Kupffer cell‐conditioned medium in vitro.

Quantification of apolipoprotein A‐I and B messenger RNA in heavy drinkers according to liver disease

P Mathurin, D Vidaud, M Vidaud, P Bedossa, V Paradis, V Ratziu, J Chaput, T Poynard – 1 January 1996 – It has previously been shown that, in heavy drinkers, serum apolipoprotein A‐I (ApoA‐I) levels are closely related to the degree of liver injury: they are at a maximum in patients with steatosis, begin to decrease in patients with fibrosis, and reach a minimum in patients with severe cirrhosis. In contrast with serum ApoA‐I variations, serum apolipoprotein B (ApoB) levels are stable.

Subscribe to